Bank of America
GRI

Bank of America’s GRI Bio GRI Stock Holding History

Bank of America’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$5 – 6195
2025
Q4 		$5 Hold
1
– – ﹤0.01% 7231
2025
Q3 		$45 Hold
1
– – ﹤0.01% 8035
2025
Q2 		$25 Buy
+1
New +$42 ﹤0.01% 8214
2025
Q1 		– Hold
0
– – – 8190
2024
Q4 		– Hold
0
– – – 7840
2024
Q3 		– Hold
0
– – – 8060
2024
Q2 		– Hold
0
– – – 8136

Other funds holding GRI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Bank of America's GRI Position: Q1 2026 in Review

Bank of America sold out of GRI Bio (GRI) in Q1 2026, closing a stake of 1 share — an estimated $5 sold.

Bank of America first reported a position in GRI in Q2 2025 and held it in 3 quarters. The position peaked at $45 in Q3 2025. 6 funds tracked by Wall St. Rank hold GRI as of Q1 2026.

  • Bank of America reported no remaining GRI Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1 GRI Bio share in Q1 2026, an estimated $5.
  • Bank of America first reported a position in GRI Bio in Q2 2025 and held it in 3 quarters.
  • Bank of America's GRI Bio position peaked at $45 in Q3 2025.
  • 6 funds tracked by Wall St. Rank held GRI Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.